Dynavax Technologies Corp
DVAXDelisted Feb 10, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029142
Dynavax Technologies Corp was delisted on Feb 10, 2026; its insiders filed their last Form 4 on Feb 11, 2026; 267 institutions reported holding it in 13F filings for Q4 2025, worth $1.73B in total; Soros Fund Management was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Dynavax Technologies Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Dynavax Technologies Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kroin David | 10% Owner | 0 | Feb 11, 2026 | 1 |
| Deep Track Capital, LP | 10% Owner | 0 | Feb 11, 2026 | 1 |
| Deep Track Biotechnology Master Fund, Ltd. | 10% Owner | 0 | Feb 11, 2026 | 1 |
| Kisner Daniel L | Director | 0 | Feb 10, 2026 | 1 |
| Silvernail Lauren P | Director | 0 | Feb 10, 2026 | 1 |
| Cano Francis | Director | 0 | Feb 10, 2026 | 1 |
| Myers Scott Dunseth | Director | 0 | Feb 10, 2026 | 1 |
| Slebir John L | SVP General Counsel | 0 | Feb 10, 2026 | 2 |
| Novack David F | President & COO | 0 | Feb 10, 2026 | 3 |
| Spencer Ryan | CEO and Director | 0 | Feb 10, 2026 | 2 |
| MacDonald Kelly | SVP and CFO | 0 | Feb 10, 2026 | 2 |
| Sun Elaine D | Director | 0 | Feb 10, 2026 | 1 |
| MacGregor Brent | Director | 0 | Feb 10, 2026 | 1 |
| Emini Emilio | Director | 0 | Feb 10, 2026 | 1 |
| Metzinger Joseph Anthony | VP, Chief Accounting Officer | 0 | Feb 10, 2026 | 2 |
| Paradiso Peter R. | Director | 24,829 | Jun 13, 2025 | 0 |
| Janssen Robert | SVP and CMO | 77,485 | Feb 20, 2025 | 0 |
| Burgess Justin | VP Finance & CAO | 4,170 | Feb 12, 2025 | 0 |
| Phillips Peggy V | Director | 43,804 | May 28, 2024 | 0 |
| Eastland Julia Marie | Director | 16,071 | May 28, 2024 | 0 |
| Hack Andrew A. F. | Director | 915,000Indirect | Aug 10, 2023 | 0 |
| Ricciardi Natale S | Director | – | May 27, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2021 (view filing) | Aug 27 | Same day | Hack Andrew A. F.Director | SSale | −2.00M | $16.22 | −$32.4M | −19.2%8.41M after | |
| Aug 25, 2021 (view filing) | Aug 24 | 1 day | Novack David FPresident & COO | SSale | −10.0K | $14.00 | −$140.0K | −8.8%104.1K after | |
| Aug 25, 2021 (view filing) | Aug 24 | 1 day | Burgess JustinPrincipal Accounting Officer | SSale | −5.77K | $15.00 | −$86.5K | −60.8%3.72K after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Janssen RobertSenior Vice President | SSale | −2.92K | $12.36 | −$36.1K | −26.1%8.28K after | |
| Aug 13, 2021 (view filing) | Aug 11 | 2 days | Novack David FPresident & COO | SSale | −10.0K | $12.00 | −$120.0K | −8.5%107.4K after | |
| Aug 13, 2021 (view filing) | Aug 11 | 2 days | Janssen RobertSenior Vice President | SSale | −49.6K | $12.06 | −$598.0K | −87.8%6.86K after | |
| Aug 11, 2021 (view filing) | Aug 9 | 2 days | Hack Andrew A. F.Director | SSale | −2.25M | $10.80 | −$24.3M | −20.9%8.52M after | |
| Aug 10, 2021 (view filing) | Aug 6 | 4 days | Janssen RobertSenior Vice President | SSale | −80.0K | $10.75 | −$860.0K | −92.1%6.86K after |